Discrepancies in Safety Reporting for Chronic Back Pain Clinical Trials: An Observational Study from ClinicalTrials.gov and Publications
February 2025
in “
BMC Medical Research Methodology
”
Studysummary This study reports that discrepancies in adverse event reporting for clinical blood pressure trials undermine the reliability of safety data, suggesting a need for standardized reporting guidelines to improve trustworthiness.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study identifies significant discrepancies in adverse event (AE) reporting for chronic back pain (CBP) clinical trials, which compromise the reliability of published safety data and pose risks to clinical decision-making and patient safety. It suggests that adopting standardized reporting guidelines like CONSORT Harms and ensuring transparent updates in publications could improve the accuracy and trustworthiness of safety data. The study calls for journals and regulatory bodies to enforce compliance and recommends developing mechanisms to monitor and correct reporting inconsistencies to enhance the trustworthiness of safety data in clinical research.
